Loading clinical trials...
Loading clinical trials...
The objective of this study is to make a massive suicide risk and social behavior assessment in 24 pre-graduate education centers in Mexico City (approximately 30,000 students aged between 15 and 22 years), taking also into account other outcomes such as depression, anxiety, alcohol and drugs. For this, an app for Smartphone (MeMind) or a web platform (www.MeMind.net) will be used in which the participants will take a self-administered questionnaire, composed of several psychometric instruments. Our main hypothesis is that identification of suicide risk in the Mexico City's student community is feasible using their own smartphones and can serve as both a population screening tool for early specialist referral, as well as a tool for evaluating social behavior strategies and their relation to suicide behavior.
Age
15 - 22 years
Sex
ALL
Healthy Volunteers
No
Alcaldía Milpa Alta. Ciudad de México
Mexico City, Mexico
Start Date
August 26, 2019
Primary Completion Date
July 1, 2020
Completion Date
August 1, 2020
Last Updated
July 7, 2020
30,000
ESTIMATED participants
Self-administered evaluation questionnaire
OTHER
Lead Sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Collaborators
NCT07360600
NCT06793397
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions